Legend Biotech Corporation
LEGN
$18.55
-$0.55-2.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.36% | 68.35% | -24.24% | -483.57% | 120.99% |
| Total Depreciation and Amortization | 103.57% | 0.43% | 12.60% | -18.79% | 63.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 145.16% | -89.16% | 116.74% | 191.51% | -188.23% |
| Change in Net Operating Assets | -165.93% | 232.63% | 51.63% | -70.64% | -21.14% |
| Cash from Operations | -142.38% | 320.83% | 87.43% | -26.46% | -8.21% |
| Capital Expenditure | -147.13% | 45.74% | -360.74% | 15.63% | -14.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4,440.19% | 90.41% | -160.43% | 402.42% | -125.83% |
| Cash from Investing | 3,292.27% | 87.92% | -164.50% | 391.97% | -126.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -59.14% | 52.34% | -62.55% | 15.36% | 21.13% |
| Issuance of Common Stock | -75.55% | 365.93% | -81.09% | 146.00% | -89.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -196.57% | 167.68% | -248.43% | 301.51% | -107.80% |
| Foreign Exchange rate Adjustments | -190.87% | -36.12% | 217.21% | 161.14% | -537.02% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4,962.61% | 107.03% | -213.01% | 189.79% | -166.88% |